Alimanio, Jolina S.
HRN: 19-71-81 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/04/2025
LEVOFLOXACIN 500MG (TAB)
11/04/2025
11/10/2025
PO
500mg
OD
T/c Lung Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: No Wrong Choice
Final appropriateness: Yes
Overall appropriateness: Yes